Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2013 FY- Text added to 2014 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ACI, acute, aeruginosa, anti, arm, AstraZeneca, Avastin, bestow, big, Biopharma, blinded, Bristol, BsAb, burden, busy, calendar, CAR, Carolina, CARTANK, Cary, checkpoint, chemotherapic, Chinese, Clin, CLL, CMC, cocktail, coined, Conference, confined, Conkwest, correlated, COSO, CRs, deteriorate, dimerization, DNA, draining, empower, estate, evenly, expeditiously, explore, exploring, exposure, faster, fatal, finite, footnote, forecast, fusion, glioblastoma, GLOBOCAN, graph, hazard, HCP, Heart, hematologic, hematological, Hodgkin, hyperplasia, hypothetical, Ib, Idiopathic, immunocellular, immunomodulatory, INAD, inadequate, incarnation, IPF, IPO, jointly, JV, Keytruda, killer, kinase, Langston, LDA, leader, leukemia, Levena, lie, logistical, LP, lymphoblastic, lymphoma, Macau, macroeconomic, Mainland, Max, Merck, mid, Mike, min, MLV, modality, Morgan, Morphotek, myc, NantBioCell, NCI, Neukoplast, NHBLI, nivolumab, NK, obligatory, OC, oncogenic, Opdivo, Oprf, Opvido, Patrick, Penn, pertain, pharmaco, Philadelphia, pilot, PPI, prespecified, pronounced, propagated, proportional, PSMA, Pulmonary, quickly, real, regular, reinvested, renewed, RL, Royal, saving, SBIR, segment, Serrono, Siegel, Squibb, stably, stake, step, sublease, subscription, topline, TRAIL, transformation, TRIBECA, TSA, tyrosine, unnecessary, unqualified, UTC, vast, vehicle, venture, vigilance
Removed:
achievability, acknowledgement, administering, administrator, affinity, allergic, attestation, bacteria, belong, body, chain, clonal, cloned, cloning, Conclusion, consistent, constant, construct, dedicated, depicted, destruction, differentiated, diseased, distinct, distinguishing, donor, dual, engineered, evidenced, fast, feasibility, fiscal, founding, fused, glenn, HAMA, humanized, identical, IgA, IgG, immortalize, improved, indemnity, inducing, infect, inflammation, inflammatory, inin, inInternal, intracellular, jane, Jolla, Journal, kill, La, light, lymphocyte, managing, manipulation, microbial, mouse, naturally, neutralize, nonrefundable, ophthalmological, opposed, pairing, par, pathogen, placement, premier, prevailing, privately, qualifying, random, reaction, recognizing, reflected, region, remain, repeatedly, reproducing, responded, screen, secondary, secretory, sequence, shorter, signature, specialty, sporadically, subtlest, tightly, today, trust, uncomfortable, uniquely, unwanted, upfront, variable, virtually, white, Winter, yeast
Valuein 2013 FY filing- Value in 2014 FY filing
Original filings
Filing view